What is the Y-tunnus number of Janssen-Cilag Oy?

Janssen-Cilag Oy is registered with PRH / YTJ under Y-tunnus 0922140-8.

What is the revenue of Janssen-Cilag Oy?

Janssen-Cilag Oy reported revenue of EUR 138,3M in 2024.

Janssen-Cilag Oy employs 130 people as of the latest annual report.

Berkeley Alexander Vincent is Chief Executive Officer of Janssen-Cilag Oy, in role since 2019.

Nina Maria Ekholm-Wenberg chairs the board of Janssen-Cilag Oy, in role since 2023.

Janssen-Cilag Oy's registered address is Hatsinanpuisto 8-B.

OYActive

Y-tunnus 0922140-8Hatsinanpuisto 8B, 02600 EspooWholesale of pharmaceutical and medical goods · NACE 4646Est. 1993130 employees

Actively employed in the business

Name	Role	Member since
Current (1)
MK Mario Klesse Chief Executive Officer	Chief Executive Officer	2025
Former (6)
BA Berkeley Alexander Vincent Chief Executive Officer	Chief Executive Officer	2019 – 2022
LÅ Lars Åke Hjalmar Johansson Chief Executive Officer	Chief Executive Officer	2011 – 2019
EA Eetu Albert Aleksi Anttonen Audit	Audit	2019 – 2023
BA Berkeley Alexander Vincent Chief Executive Officer	Chief Executive Officer	2019 – 2019
LL Leena Lisette Puumala Audit	Audit	2014 – 2019
DJ Duarte Joäo Lourinho Marchand Chief Executive Officer	Chief Executive Officer	2023 – 2025

Non-executive oversight

Name	Role	Member since
Current (4)
KL Katriina Liina Maria Ingman	Board of Directors	2022
NM Nina Maria Ekholm-Wenberg	Chairperson	2023
RP Raphaël Patricot	Board of Directors	2024
AN Ari-Pekka Naumanen	Board of Directors	2023
Former (7)
PJ Pekka Juhani Ihalmo	Board of Directors	2018 – 2021
TT Terhi Tuuli Elina Lampen	Board of Directors	2018 – 2022
LC Lotta Carola Karlsson	Board of Directors	2022 – 2022
TJ Timothy James House	Board of Directors	2022 – 2024
JA Jukka Arlak Karppinen	Board of Directors	2018 – 2022
SM Susanna Maria Rantala	Board of Directors	2019 – 2022
LJ Liisa Johanna Backman-Laukkanen	Board of Directors	2018 – 2019

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.